Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection. (2021)

First Author: Williams TL
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s42003-021-02453-y

PubMed Identifier: 34326460

Publication URI: http://europepmc.org/abstract/MED/34326460

Type: Journal Article/Review

Volume: 4

Parent Publication: Communications biology

Issue: 1

ISSN: 2399-3642